| Browse All

LENSAR, Inc. (LNSR)

Healthcare | Medical Devices | Orlando, United States | NasdaqCM
5.55 USD -0.38 (-6.408%) ⇩ (April 20, 2026, 4 p.m. EDT)

Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 19, 2026, 12:05 a.m. EDT

LENSAR presents a 'Strong Buy' technically and analyst-wise, yet remains a 'Sell' fundamentally due to severe cyclic business risks and earnings deterioration. The stock is trading at a massive discount to its 50-day average (-35%) versus its 200-day average, creating a divergent technical signal. While the $50M credit line and European target framework are strong positives, the FTC regulatory uncertainty and negative operating margins (-116%) make it an aggressive speculative trade rather than a core holding. The optimal entry leverages the spread between analysts targeting $8.50 and the current depressed price of $5.93.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.257588
MSTL0.263573
AutoTheta0.294260
AutoARIMA0.318462

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 29%
H-stat 409.71
Ljung-Box p 0.000
Jarque-Bera p 0.023
Excess Kurtosis -1.41
Attribute Value
Sector Healthcare
Revenue per Share 4.887
Market Cap 67,130,752
Forward P/E -7.82
Beta 0.99
Profit Margins -58.66%
Website https://www.lensar.com

As of April 19, 2026, 12:05 a.m. EDT: Sentiment is mixed with a slight bullish skew based on Call positioning. In the May 2026 expiry, significant volume/delta entered at the $7.50 strike (+26.5% vol change), indicating a target price upside of roughly 25-30%. However, the $5.00 strike (ATM/ITM) shows heavy activity with high implied volatility (IV > 1.5), suggesting a sticky floor and defensive positioning. Long-dated options (Oct) show heavy Out-of-the-Money (OTM) Open Interest at $15.00, representing a long-term upside target, while Put activity remains concentrated at nearby $5.00 strikes, implying a limit rather than a crash expectation.


Info Dump

Attribute Value
52 Week Change -0.5984081
Address1 2,800 Discovery Drive
All Time High 17.31
All Time Low 1.8
Ask 5.65
Ask Size 1
Audit Risk 8
Average Analyst Rating 1.0 - Strong Buy
Average Daily Volume10 Day 93,330
Average Daily Volume3 Month 113,157
Average Volume 113,157
Average Volume10Days 93,330
Beta 0.985
Bid 5.45
Bid Size 1
Board Risk 6
Book Value -2.17
City Orlando
Compensation As Of Epoch Date 1,735,603,200
Compensation Risk 8
Country United States
Crypto Tradeable 0
Currency USD
Current Price 5.55
Current Ratio 1.153
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 5.94
Day Low 5.48
Display Name LENSAR
Earnings Call Timestamp End 1,774,960,200
Earnings Call Timestamp Start 1,774,960,200
Earnings Timestamp 1,774,960,200
Earnings Timestamp End 1,778,157,000
Earnings Timestamp Start 1,778,157,000
Ebitda -20,076,000
Ebitda Margins -0.34355998
Enterprise To Ebitda -3.271
Enterprise To Revenue 1.124
Enterprise Value 65,671,752
Eps Current Year -0.08
Eps Forward -0.71
Eps Trailing Twelve Months -2.87
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 8.9759
Fifty Day Average Change -3.4258995
Fifty Day Average Change Percent -0.38167757
Fifty Two Week Change Percent -59.84081
Fifty Two Week High 14.31
Fifty Two Week High Change -8.76
Fifty Two Week High Change Percent -0.6121593
Fifty Two Week Low 5.33
Fifty Two Week Low Change 0.22000027
Fifty Two Week Low Change Percent 0.041275848
Fifty Two Week Range 5.33 - 14.31
Financial Currency USD
First Trade Date Milliseconds 1,601,645,400,000
Float Shares 8,674,261
Forward Eps -0.71
Forward P E -7.8169017
Free Cashflow 8,279,750
Full Exchange Name NasdaqCM
Full Time Employees 150
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,775,001,600
Gross Margins 0.46414003
Gross Profits 27,122,000
Has Pre Post Market Data 1
Held Percent Insiders 0.18827999
Held Percent Institutions 0.48973
Implied Shares Outstanding 12,095,631
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Long Business Summary LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Long Name LENSAR, Inc.
Market us_market
Market Cap 67,130,752
Market State PRE
Max Age 86,400
Message Board Id finmb_41699596
Most Recent Quarter 1,767,139,200
Net Income To Common -34,280,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 67,130,752
Number Of Analyst Opinions 2
Open 5.88
Operating Cashflow -14,831,000
Operating Margins -1.1602501
Overall Risk 9
Payout Ratio 0.0
Phone 888 536 7271
Pre Market Change 0.35999966
Pre Market Change Percent 6.48648
Pre Market Price 5.91
Pre Market Time 1,776,772,198
Previous Close 5.93
Price Eps Current Year -69.37501
Price Hint 2
Price To Book -2.5576036
Price To Sales Trailing12 Months 1.1488106
Profit Margins -0.58663
Quick Ratio 0.6
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.0
Region US
Regular Market Change -0.38
Regular Market Change Percent -6.40809
Regular Market Day High 5.94
Regular Market Day Low 5.48
Regular Market Day Range 5.48 - 5.94
Regular Market Open 5.88
Regular Market Previous Close 5.93
Regular Market Price 5.55
Regular Market Time 1,776,715,201
Regular Market Volume 143,497
Return On Assets -0.22307
Return On Equity -10.694119
Revenue Growth -0.042
Revenue Per Share 4.887
Sand P52 Week Change 0.34445214
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 10
Shares Outstanding 12,095,631
Shares Percent Shares Out 0.084
Shares Short 1,016,420
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 717,187
Short Name LENSAR, Inc.
Short Percent Of Float 0.1034
Short Ratio 4.97
Source Interval 15
State FL
Symbol LNSR
Target High Price 10.0
Target Low Price 7.0
Target Mean Price 8.5
Target Median Price 8.5
Total Cash 17,978,000
Total Cash Per Share 1.486
Total Debt 2,735,000
Total Revenue 58,435,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -2.87
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 11.275225
Two Hundred Day Average Change -5.7252245
Two Hundred Day Average Change Percent -0.5077703
Type Disp Equity
Volume 143,497
Website https://www.lensar.com
Zip 32,826